Invests in
Locations:
Min Investment:
$5,000.00Max Investment:
$50,000.00Target Investment:
$25,000.00
Skills
Education
- HB
- HU
- HT
- CW
- DC
Lists including Scott
Work Experience
Attending Radiologist
1992
Vice Chairman, Academic Advancement
2018
Vice Chairman for Faculty Affairs
2010 - 2018
Developed and implemented programs that support recruitment, credentialing, maintenance of certification, career advancement, promotion and leadership development for >450 faculty members.
Associate Vice Chairman for Research
2006 - 2018
Overall responsibility for research finance and operations. The department has the largest radiology research program in the world, with approximately $100 million in annual research expenditures.
Director, Breast Imaging
2013 - 2015
Founding Director, Institute for Technology Assessment
1998 - 2015
The ITA (www.mgh-ita.org) is one of the largest and most successful programs of its kind, with approximately 65 full-time faculty, staff and trainees and $30 million in active research funding. We conduct research to guide the development, evaluation and appropriate use of medical technologies and clinical programs that can improve the quality and cost-effectiveness of health care.
Associate Director, Center for Imaging and Pharmaceutical Research
1992 - 1998
Led efforts to develop blood-pool contrast agents for CT and ultrasound. Also established and led program to develop and evaluate equipment and techniques for radiofrequency tumor ablation.
2015
Co-Founder
2015
Director Emeritus
2015
2005
Professor of Radiology
2005
2006 - 2018
Professor in the Department of Health Policy and Management
2006 - 2018
Founding Director
2002 - 2018
The Program in Cancer Outcomes Research Training is a multi-disciplinary training program that spans the hospitals and affiliated institutions of the Dana-Farber/Harvard Cancer Center. Its goal is to train leaders in cancer outcomes research.
2014 - 2015
Consultant
2014 - 2015
Co-Founder and Co-Director
1995 - 1999
The CCTR was established to facilitate the involvement of researchers from the Brigham and Women's and Massachusetts General Hospitals in clinical trials of new imaging pharmaceuticals, devices and techniques.